AKT1 and acute myeloid leukemia: Among the biochemical mechanisms abnormally elevated in malignancies, including acute myeloid leukemia, is the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin route (PI3K-Akt-mTOR pathway) [186].